Building the Pipeline for Tomorrow's Cures
We are architects of the future of medicine, actively building our investment portfolio for a dedicated life sciences fund. While we secure our capital, our focus is on forging early,
strategic alliances with the most promising Pre-Series A and Series A companies in the life sciences ecosystem.

Our Mission: Strategic Sourcing & Founder Partnership

We identify and deeply vet visionary founders developing
transformative therapies, platforms, and technologies. For a select group of
pioneers, we engage in a pre-investment partnership, providing strategic
counsel to strengthen their operational readiness and investment narrative.

• Active Deal Sourcing: Identifying and vetting high-potential life science startups.
• Strategic Capital Introduction: Connecting validated startups with our network of institutional investors.

• We are actively scouting for companies pioneering:

1. AI Algorithms for Therapeutic Platforms
2. Medicinal Modalities (Cell & Gene Therapies, mRNA, etc.)
3. Enabling Technologies for Drug Development and Manufacturing (AI powered clinical trials management, bioprocessing tech, algorithms to predict the rate of commercial success etc.)
4. AI powered med tech, health tech, wearable tech, life sciences tools (algorithms, novel technologies etc.)

For Founders:
If you are building the future of medicine and believe in the power of a
strategic alliance to prepare for scale, we should speak.

Contact or venture team at zein@zelarisventures.com.